R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2018, CA: Cancer J. Clin. 68 (2018) 7–30. https://doi.org/10.3322/caac.21442.
 M.T. Moyer, R.R. Gaffney, Pancreatic adenocarcinoma, N. Engl. J. Med. 371 (2014) 2140. https://doi.org/10.1056/NEJMc1412266.
 C.S. Nowell, F. Radtke, Notch as a tumour suppressor, Nat. Rev. Cancer 17 (2017) 145–159. https://doi.org/10.1038/nrc.2016.145.
 O. Meurette, P. Mehlen, Notch signaling in the tumor microenvironment, Cancer Cell 34 (2018) 536–548. https://doi.org/10.1016/j.ccell.2018.07.009.
 S. Sawaguchi, S. Varshney, M. Ogawa, Y. Sakaidani, H. Yagi, K. Takeshita, T. Murohara, K. Kato, S. Sundaram, P. Stanley, T. Okajima, O-GlcNAc on NOTCH1 EGF repeats regulates ligand-induced Notch signaling and vascular development in mammals, Elife 6 (2017) e24419. https://doi.org/10.7554/ eLife.24419.
 K.C. Schröder, D. Duman, M. Tekin, D. Schanze, M. Sukalo, J. Meester, W. Wuyts, M. Zenker, Adams–Oliver syndrome caused by mutations of the EOGT gene, Am. J. Med. Genet. A 179 (2019) 2246–2251. https://doi.org/10.1002/ajmg.a.61313.
 Z. Zhang, H. Han, Y. Rong, K. Zhu, Z. Zhu, Z. Tang, C. Xiong, J. Tao, Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling, J. Exp. Clin. Cancer Res. 37 (2018) 291–291. https://doi.org/10.1186/ s13046-018-0972-3.
 S. Kunnimalaiyaan, J. Trevino, S. Tsai, T.C. Gamblin, M. Kunnimalaiyaan, Xanthohumol-mediated suppression of Notch1 signaling is associated with antitumor activity in human pancreatic cancer cells, Mol. Cancer Ther. 14 (2015) 1395–1403. https://doi.org/10.1158/1535-7163. MCT-14-0915.
 R. Schmandt, S.K. Liu, C.J. McGlade, Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells, Oncogene 18 (1999) 1867–1879. https://doi.org/10.1038/sj.onc.1202507.
 E. Asano, H. Hasegawa, T. Hyodo, S. Ito, M. Maeda, D. Chen, M. Takahashi, M. Hamaguchi, T. Senga, SHCBP1 is required for midbody organization and cytokinesis completion, Cell Cycle 13 (2014) 2744–2751. https://doi.org/10.4161/15384101. 2015.945840.
 J. Chen, F. Lai, L. Niswander, The ubiquitin ligase mLin41 temporally promotes neural progenitor cell maintenance through FGF signaling, Genes Dev. 26 (2012) 803–815. https://doi.org/10.1101/gad.187641.112.
 W. Feng, H.C. Li, K. Xu, Y.F. Chen, L.Y. Pan, Y. Mei, H. Cai, Y.M. Jiang, T. Chen, D.X. Feng, SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line, Gene 587 (2016) 91–97. https://doi.org/10.1016/j.gene.2016.04.046.
 L. Liu, Y. Yang, S. Liu, T. Tao, J. Cai, J. Wu, H. Guan, X. Zhu, Z. He, J. Li, E. Song, M. Zeng, M. Li, EGF-induced nuclear localization of SHCBP1 activates β-catenin signalingand promotes cancer progression, Oncogene 38 (2018) 747–764. https://doi.org/ 10.1038/s41388- 018-0473-z.
 N. Xu, Y.P. Wu, H.B. Yin, S.H. Chen, X.D. Li, X.Y. Xue, X. Gou, SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis, J. Cancer Res. Clin. Oncol. 146 (2020) 1953–1969. https://doi.org/10.1007/s00432-020-03247-1.
 R. Shah, K.T. Ostapoff, B. Kuvshinoff, S.N. Hochwald, Ablative therapies for locally advanced pancreatic cancer, Pancreas 47 (2018) 6–11. https://doi.org/10.1097/mpa. 0000000000000948.
 G.Y. Zhang, Z.J. Ma, L. Wang, R.F. Sun, X.Y. Jiang, X.J. Yang, B. Long, H.L. Ye, S.Z. Zhang, Z.Y. Yu, W.G. Shi, Z.Y. Jiao, The role of Shcbp1 in signaling and disease, Curr. Cancer Drug Targets 19 (2019) 854–862. https://doi.org/10.2174/ 1568009619666190620 114928.
 N. Wang, M.Y. Li, Y. Liu, J. Yu, J. Ren, Z. Zheng, S. Wang, S. Yang, S.L. Yang, L.P. Liu, B.G. Hu, C.C. Chong, J.L. Merchant, P.B. Lai, G.G. Chen, ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway, Cancer Lett. 472 (2020) 70–80. https://doi.org/10.1016/j.canlet.2019.12.026.
 Y. Chen, Z. Li, M. Zhang, B. Wang, J. Ye, Y. Zhang, D. Tang, D. Ma, W. Jin, X. Li, S. Wang, Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma, J. Exp. Clin. Cancer Res. 38 (2019) 466–466. https://doi.org/10.1186/s13046-019-1436-0.
 J. Lee, J. Lee, J.H. Kim, Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer, Cell. Oncol. (2020). https://doi.org/10.1007/ s13402-020-00527-3.
 K. Song, Q. Li, Y.B. Peng, J. Li, K. Ding, L.J. Chen, C.H. Shao, L.J. Zhang, P. Li, Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling, Biochem. J. 436 (2011) 271–282. https://doi.org/10.1042/bj20110297.
 X. Yang, K. Qian, Protein O-GlcNAcylation: emerging mechanisms and functions, Nat. Rev. Mol. Cell Biol. 18 (2017) 452–465. https://doi.org/10.1038/nrm.2017.22.
 A.B. Stittrich, A. Lehman, D.L. Bodian, J. Ashworth, Z. Zong, H. Li, P. Lam, A. Khromykh, R.K. Iyer, J.G. Vockley, R. Baveja, E.S. Silva, J. Dixon, E.L. Leon, B.D. Solomon, G. Glusman, J.E. Niederhuber, J.C. Roach, M.S. Patel, Mutations in NOTCH1 cause Adams-Oliver syndrome, Am. J. Hum. Genet. 95 (2014) 275–284. https://doi.org/10.1016/j.ajhg.2014.07.011.
 Z. Liu, E. Brunskill, B. Varnum-Finney, C. Zhang, A. Zhang, P.Y. Jay, I. Bernstein, M. Morimoto, R. Kopan, The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis, Development 142 (2015) 2452–2463. https://doi.org/10.1242/dev.125492.
 H. Zhou, L. Gao, Z.H. Yu, S.J. Hong, Z.W. Zhang, Z.Z. Qiu, LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR‐124, Nephrology 24 (2019) 472–480. https://doi.org/10.1111/nep.13394.
 D.H. Luo, Q. Zhou, S.K. Hu, Y.Q. Xia, C.C. Xu, T.S. Lin, Y.T. Pan, J.S. Wu, R. Jin, Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer, Oncol. Lett. 7 (2013) 471–478.https://doi.org/10.3892/ol. 2013.1751.
 Lu H Y , Chu H X , Tan Y X , et al. Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo[J]. Life ences, 2020, 244:117343. https://doi.org/10.1016/ j.lfs.2020.117343
 T. Hamidi, C.E. Cano, D. Grasso, M.N. Garcia, M.J. Sandi, E.L. Calvo, et al., Nupr1- aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death, Clin. Cancer Res. 18 (2012) 5234e5246. https://doi.org/
 S. Chen, J. Chen, Q. Zhan, Y. Zhu, H. Chen, X. Deng, et al., H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma, Oncotarget 5 (2014) 10421.
 Tang D , Yan T , Zhang J , et al. Notch1 Signaling Contributes to Hypoxia-induced High Expression of Integrin β1 in Keratinocyte Migration[J]. Scientific Reports, 2017, 7:43926. https://doi.org/10.18632/oncotarget.2126
 AlkholiefM , Campbell R B . Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: an in vitro study[J]. Nanomedicine, 2016:1291-1302. https://doi.org/10.1016/j.nano.2016.01.007